SOURCE: Spruce Capital Partners

Spruce Capital Partners

July 17, 2015 14:54 ET

Spruce Capital Partners' Ganesh Kishore and Roger Wyse to Address 12th Annual BIO World Congress on Industrial Biotechnology

SAN FRANCISCO, CA--(Marketwired - Jul 17, 2015) - Spruce Capital Partners' Managing Partners Dr. Ganesh Kishore and Dr. Roger Wyse, industrial biotechnology thought leaders and investors, will be featured at the 12th Annual BIO World Congress on Industrial Biotechnology.

The event, which is being held at the Palais des Congres de Montreal July 19 to 22, 2015, is the largest international industrial biotech event. It will bring together more than 1,300 leaders in advanced biofuels, biobased products, and renewable chemicals.

Dr. Wyse will speak during the GreenTech Investor Perspectives on Industrial Biotechnology at 8:40 a.m. Monday, July 20. Dr. Kishore will participate in a panel discussion VC's Perspective on Financing Research to Commercialization for Renewable Chemical and Biofuel Projects July 21, at 2:30 p.m.

Dr. Wyse will discuss Spruce Capital Partners' investment strategy and its focus on cutting edge science and technology to address significant societal needs in industrial biotechnology, agriculture, and food and nutrition in early- through mid-stage innovative companies. The firm, through its deep network of global relationships, accelerates commercialization by linking businesses with opportunities in emerging markets. Through work with its partners, it promotes and supports open innovation strategies to accelerate technology and advance companies to profitability.

"The use of biotechnology to address serious societal challenges represents significant opportunities with the potential to generate superior returns," says Dr. Roger Wyse, Managing Partner of Spruce Capital Partners. "We are funding companies that are harnessing biology to improve productivity, sustainability, quality, and affordability."

Dr. Kishore will discuss the opportunity for bioindustrial companies to focus on high-value, specialty chemicals. He argues that biology is uniquely geared to make more functional and complex molecules instead of simply chasing the "drop in" substitutes in fuels and commodity chemicals. While this has been the focus of the application of biology in agriculture, human and animal nutrition, wellness and disease management, most of the applications in the industrial sector have been focused on chasing hydrocarbons with a low degree of functionality and often, toxicity to the organisms producing them.

Though much of the efforts in this area have focused on biofuels, he argues the reality is that bioindustry needs to compete against oil at $30 to $45 a barrel, not the $85 to $105 that had been the opportunity until recently. At current prices, fuel is not as competitive as a target for investments, especially in the U.S. market, or in specific sectors and geographies where regulations and objectives are being enforced.

"There is no question that the industrial bioeconomy has the potential to be a bigger element of our global economy and spawn businesses that enhance global sustainability and availability," says Dr. Kishore. "As entrepreneurs and venture investors, we believe that we have to focus on a new industrial sector that can serve customer and consumer needs that are either unmet or underserved, and the value created is significant and tangible." 

About Spruce Capital Partners
The principals and founders of Spruce Capital Partners, Dr. Ganesh Kishore, Dr. Roger Wyse, and Greg Young, are well known investors and thought leaders in the biogreentech sector. They bring a wealth of experience as investors, advisers, and domain experts in helping entrepreneurs build the next generation of successful biogreentech companies. They formed Spruce Capital Partners not only to manage venture funds, but also to develop new talent for the industry, provide thought leadership, and promote innovation in companies and countries. The principals have worked together for more than 10 years and have shepherded investments across multiple funds and multiple sectors. They are also active in advising, partnering, and shaping the life sciences industry globally and, especially in Malaysia and United States. Spruce Capital Partners is a co-manager of the MLS Capital Fund II. Additional information is available at www.sprucecp.com.

Contact Information

  • Contact
    Daniel Levine
    Levine Media Group
    Email Contact
    (510) 280-5405